ACM Biolabs Further Strengthens Leadership, Appoints David L

SINGAPORE, April 11, 2023 /PRNewswire/ -- ACM Biolabs (FR0012596468 - ALSEN) a pioneering Singaporean-Swiss biotechnology company, which specializes in the development of targeted therapeutics

Related Keywords

Paris , France General , France , Singapore , Chiron , Centre , Switzerland , Swiss , Singaporean , David Lawrence , Madhavan Nallani , Boards Of Enterobiotix , Synpromics Ltd , Business Development , Enterobiotix Ltd , Nasdaq , Artificial Cell Membranes , Chief Financial Officer , Euronext Growth , Management Board , Investor Relations , Public Offering , Venture Capital , Chief Executive Officer , Tunable Platform , Biolabs , Urther , Trengthens , Leadership , Ppoints , David , Lawrence , Board , Directors ,